MedTrace Logo

Neurofeedback for Post-Traumatic Stress Disorder

NCT05123690 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-04-13

No results posted yet for this study

Summary

A two-arm randomized pilot of standard neurofeedback and a waiting list for patients with treatment resistent PTSD.

Conditions

  • Post-traumatic Stress Disorder

Interventions

DEVICE

Neurofeedback

A device that assists in training patients in relaxing.

Sponsors & Collaborators

  • Steinn Steingrimsson

    lead OTHER

Principal Investigators

  • Steinn Steingrimsson, PhD · Sahlgrenska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05123690 on ClinicalTrials.gov